Control or Mitigation of the Effects of Chronic Neuroinflammation - 2022 World Medical Innovation Forum

Control or Mitigation of the Effects of Chronic Neuroinflammation

Control or Mitigation of the Effects of Chronic Neuroinflammation

Tuesday, May 3, 2022

4:35 PM – 5:15 PM America Ballroom View Here

Chronic inflammation in the brain is now recognized as a contributor to many neurodegenerative diseases, ranging from Parkinson’s disease to multiple sclerosis to Alzheimer’s disease. Are solutions to these historically intractable neurological diseases imminent or several years away? Are market-making platforms identifiable for neurological diseases? Are there novel genetic targets that can be explored? What are the prospects for cell therapies?

Moderator:
Ole Isacson, MD, PhD
  • Director, Neuroregeneration Research Institute, McLean
  • Professor of Neurology & Neuroscience, HMS
Panelists:
Colin Hill
  • CEO, GNS Healthcare
Spyros Papapetropoulos, MD, PhD
  • CMO, Vigil Neuroscience
Richard Ransohoff, MD
  • CMO, Abata Therapeutics
  • Venture Partner, Third Rock Ventures
Beth Stevens, PhD
  • HHMI Investigator, F.M. Kirby Neurobiology Research Program, Boston Children's Hospital
  • Associate Professor of Neurology, HMS
Rudolph Tanzi, PhD
  • Vice-Chair, Neurology, Director, Genetics and Aging Research Unit, MGH
  • Joseph P. and Rose F. Kennedy Professor of Neurology, HMS